Frameless Stereotactic Radiosurgery for Brain Metastases
Launched by ALBERTA HEALTH SERVICES · Nov 18, 2011
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with brain metastases from a biopsy-proven primary extra-cranial tumor site, excluding lymphoma, germ cell, and small cell lung carcinoma histologies.
- • One to four metastases, and all lesions \< 3.5 cm in maximal diameter. Extracranial metastases is of minimal volume or stable with treatment. - Karnofsky performance status ≥ 70
- Exclusion Criteria:
- • None of the lesions is abutting or within critical neurological structures: \*brainstem
- • optic chiasm
- • eye, and optic nerve.
- • The clearance between metastatic lesions and all critical structures must be at least 2 mm.
- • Patients must not have leptomeningeal disease.
- • Contraindications to imaging or radiation (e.g. pregnancy, elevated serum creatinine, allergy to contrast agents, severe claustrophobia, metal particles in the eye).
Trial Officials
Jon-Paul Voroney, MD
Principal Investigator
Tom Baker Cancer Centre
About Alberta Health Services
Alberta Health Services (AHS) is a prominent healthcare organization dedicated to delivering comprehensive health services across Alberta, Canada. As the largest fully-integrated health system in Canada, AHS plays a pivotal role in advancing medical research and clinical trials, aiming to improve patient outcomes and healthcare delivery. The organization collaborates with a diverse array of stakeholders, including academic institutions and industry partners, to foster innovation in health practices and therapies. With a commitment to evidence-based medicine, AHS supports clinical research initiatives that enhance the understanding of health challenges and contribute to the development of effective interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
